Trial Profile
A Randomized, Single Blind, Controlled, Longitudinal Study of the Effects of Venlafaxine Hydrochloride Capsules on the Language Function of Stroke Patients With Subcortical Aphasia Using fMRI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2021
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary)
- Indications Aphasia; Stroke complications
- Focus Therapeutic Use
- 08 Sep 2019 Status changed from recruiting to completed.
- 07 Sep 2018 Status changed from not yet recruiting to recruiting.
- 20 Jul 2018 New trial record